Resources

Drug services professional

Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country.  Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.

Showing 281 to 290 of 294 resources

  • Webinar: Hepatitis C Outreach
    Outreach hepatitis C care, including ‘pop-up’ clinics, as well as the use of testing vans, is a crucial aspect of the hepatitis C elimination programme. Such outreach work, which does not rely on static services to deliver care, can be an important way to reach people who are the most under-served by these services. This webinar covered the importance of outreach, as well as specific good practice examples, such as van-based outreach work, pop-up testing during the Covid-19 pandemic and Point of Care Test and Treat outreach in the West Midlands.
    UK, England 25 May 2021 Case study, Strategy & Planning Video
  • Webinar: Hepatitis C service recovery in England
    This HCV Action webinar, which took place on 26th March 2021, examined how hepatitis C services have been maintained in England during the COVID-19 pandemic and looked at plans to expand service provision over the next few months. Speakers: - Prof Graham Foster, National Clinical Lead for ODNs, NHS England - Mark Gillyon-Powell, Head of Programme – HCV Elimination, NHS England/NHS Improvement - Stacey Smith, Director of Nursing, Humankind - Colin Lawton, Northern Regional Prison Lead, The Hepatitis C Trust - Julia Sheehan, Women’s Prisons Peer Coordinator, The Hepatitis C Trust
    England 29 Mar 2021 Training, Strategy & Planning Video
  • Webinar: Measuring progress towards hepatitis C elimination
    Each nation in the UK has set rapidly approaching targets for eliminating hepatitis C; many areas and services in the community and prisons have done the same. Being able to measure what such "microelimination" looks like will be critical to both celebrating and maintaining this achievement. This HCV Action webinar, held on Zoom on 7th July 2021, heard presentations from Public Health England, NHS England, NHS Tayside and the Practice Plus Group. Following the presentations, there was an opportunity for attendees to participate in a Q&A session to ask questions and share best practice.
    UK 20 Jul 2021 Training, Reports & Research, Strategy & Planning Video
  • Webinar: Mitigating the impact of COVID-19 on hepatitis C testing
    This is a recording of a webinar focusing on how services can mitigate the impact of COVID-19 on hepatitis C testing and find alternative ways to test people. The first part of the webinar consisted of three presentations: 1/ Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You 2/ Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team 3/ Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow Live
    UK 22 Oct 2020 Case study, Tools & Templates, Strategy & Planning Video
  • Webinar: Under-served groups for hepatitis C testing and treatment
    This webinar sought to look at how services can provide hepatitis C testing and treatment to people who have been traditionally under-served by health services. This workshop sought to discuss: - Sex workers - Gypsy, Roma and Traveller people - South Asian communities - Migrants For each of these groups, this video features a presentation exploring the general barriers to healthcare that they face and examples of projects which have improved access to healthcare for them along with a Q&A session at the end.
    UK 22 Oct 2020 Case study, Training, Strategy & Planning Video
  • WHO policy brief on access to testing and treatment for people who inject drugs and people in prisons
    The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.
    UK, Rest of World 17 May 2019 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Wirral Drug and Alcohol Addiction Team (DAAT) Hep C Strategy
    The National Treatment Agency’s (NTA) aspirational target is for each DAAT partnership to ensure that 100% of their previous/current injecting drug user (IDU) population to have been tested for Hepatitis C. Many DAATs across the country have struggled to achieve this target and Wirral DAAT’s performance at the end of 2007/08 is at 20%.
    North West 2011 Case study, Strategy & Planning PDF
  • Working Together to Reduce Harm (Substance Misuse) Delivery Plan 2016 - 2018
    This Welsh Government delivery plan describes the work that will be undertaken reduce the harm caused by substance misuse. It includes actions related to hepatitis C such as the implementation of routine opt-out testing in substance misuse services.
    UK, Wales Sep 2016 Strategy & Planning PDF
  • Workshop webinar: Hepatitis C in the justice system - going beyond prisons
    This is a recording of a webinar covering initiatives to test and treat people for hepatitis C in contact with the justice system in England, held on the 23rd October 2020. Previous events and initiatives in this area have aimed to support people in prisons. Whilst this is important and continues, this webinar focused on new initiatives for people in contact with other areas of the justice system, such as probation services. The webinar featured 3 talks:
    North East, UK 29 Oct 2020 Case study, Strategy & Planning Video
  • World Health Organisation (WHO) Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection
    These are the first guidelines dealing with hepatitis C treatment produced by the World Health Organization (WHO) and complement existing guidance on the prevention of transmission of bloodborne viruses, including HCV. They are intended for policy-makers, government officials, and others working in low- and middle income countries who are developing programmes for the screening, care and treatment of persons with HCV infection.
    Rest of World Apr 2014 Tools & Templates, Strategy & Planning PDF

Pages